Bastide Le Confort Médical Past Earnings Performance
Past criteria checks 1/6
Bastide Le Confort Médical has been growing earnings at an average annual rate of 12.2%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 10.1% per year. Bastide Le Confort Médical's return on equity is 14.5%, and it has net margins of 1.2%.
Key information
12.2%
Earnings growth rate
11.9%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 10.1% |
| Return on equity | 14.5% |
| Net Margin | 1.2% |
| Next Earnings Update | 23 Oct 2024 |
Recent past performance updates
Recent updates
Is Now An Opportune Moment To Examine Bastide Le Confort Médical SA (EPA:BLC)?
Apr 27
Investors Can Find Comfort In Bastide Le Confort Médical's (EPA:BLC) Earnings Quality
Apr 06Benign Growth For Bastide Le Confort Médical SA (EPA:BLC) Underpins Stock's 26% Plummet
Mar 28Positive Sentiment Still Eludes Bastide Le Confort Médical SA (EPA:BLC) Following 28% Share Price Slump
Feb 08The Return Trends At Bastide Le Confort Médical (EPA:BLC) Look Promising
Nov 18What Is Bastide Le Confort Médical SA's (EPA:BLC) Share Price Doing?
May 17Bastide Le Confort Médical (EPA:BLC) Is Doing The Right Things To Multiply Its Share Price
Jan 27Is Bastide Le Confort Médical SA (EPA:BLC) Potentially Undervalued?
Nov 22Bastide Le Confort Médical (EPA:BLC) Is Reinvesting At Lower Rates Of Return
Sep 21Is It Time To Consider Buying Bastide Le Confort Médical SA (EPA:BLC)?
Jul 28When Should You Buy Bastide Le Confort Médical SA (EPA:BLC)?
Mar 18Be Wary Of Bastide Le Confort Médical (EPA:BLC) And Its Returns On Capital
May 16Here's Why Bastide Le Confort Médical (EPA:BLC) Has A Meaningful Debt Burden
Apr 30We Think Bastide Le Confort Médical's (EPA:BLC) Profit Is Only A Baseline For What They Can Achieve
Apr 07Should You Think About Buying Bastide Le Confort Médical SA (EPA:BLC) Now?
Mar 10Is Bastide Le Confort Médical SA's (EPA:BLC) 16% ROE Better Than Average?
Feb 21Bastide Le Confort Médical SA's (EPA:BLC) Intrinsic Value Is Potentially 33% Above Its Share Price
Feb 07
Revenue & Expenses BreakdownBeta
How Bastide Le Confort Médical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 523 | 6 | 240 | 0 |
| 30 Sep 23 | 516 | 11 | 235 | 0 |
| 30 Jun 23 | 508 | 16 | 230 | 0 |
| 31 Dec 22 | 495 | 18 | 224 | 0 |
| 30 Sep 22 | 482 | 16 | 216 | 0 |
| 30 Jun 22 | 468 | 14 | 207 | 0 |
| 31 Dec 21 | 446 | 13 | 194 | 0 |
| 30 Sep 21 | 445 | 13 | 191 | 0 |
| 30 Jun 21 | 444 | 13 | 189 | 0 |
| 31 Mar 21 | 436 | 12 | 188 | 0 |
| 31 Dec 20 | 428 | 11 | 186 | 0 |
| 30 Sep 20 | 405 | 11 | 178 | 0 |
| 30 Jun 20 | 383 | 12 | 170 | 0 |
| 31 Mar 20 | 365 | 9 | 162 | 0 |
| 31 Dec 19 | 347 | 7 | 154 | 0 |
| 30 Sep 19 | 341 | 6 | 155 | 0 |
| 30 Jun 19 | 336 | 6 | 156 | 0 |
| 31 Mar 19 | 328 | 7 | 150 | 0 |
| 31 Dec 18 | 321 | 9 | 145 | 0 |
| 30 Sep 18 | 305 | 8 | 137 | 0 |
| 30 Jun 18 | 289 | 7 | 128 | 0 |
| 31 Mar 18 | 267 | 6 | 120 | 0 |
| 31 Dec 17 | 245 | 5 | 112 | 0 |
| 30 Sep 17 | 232 | 5 | 106 | 0 |
| 30 Jun 17 | 218 | 5 | 100 | 0 |
| 31 Mar 17 | 211 | 6 | 96 | 0 |
| 31 Dec 16 | 203 | 7 | 93 | 0 |
| 30 Sep 16 | 198 | 7 | 91 | 0 |
| 30 Jun 16 | 192 | 7 | 88 | 0 |
| 31 Mar 16 | 187 | 7 | 86 | 0 |
| 31 Dec 15 | 182 | 7 | 83 | 0 |
| 30 Sep 15 | 177 | 7 | 81 | 0 |
| 30 Jun 15 | 171 | 7 | 79 | 0 |
| 31 Mar 15 | 166 | 7 | 76 | 0 |
| 31 Dec 14 | 160 | 6 | 73 | 0 |
| 30 Sep 14 | 156 | 6 | 72 | 0 |
| 30 Jun 14 | 152 | 5 | 70 | 0 |
| 31 Mar 14 | 148 | 5 | 68 | 0 |
| 31 Dec 13 | 143 | 5 | 65 | 0 |
| 30 Sep 13 | 139 | 4 | 64 | 0 |
| 30 Jun 13 | 134 | 4 | 62 | 0 |
Quality Earnings: BLC has a large one-off loss of €6.3M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: BLC's current net profit margins (1.2%) are lower than last year (3.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BLC's earnings have grown by 12.2% per year over the past 5 years.
Accelerating Growth: BLC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: BLC had negative earnings growth (-64.6%) over the past year, making it difficult to compare to the Healthcare industry average (2%).
Return on Equity
High ROE: BLC's Return on Equity (14.5%) is considered low.